Tamoxifen Fails to Deliver on Clinical Promise for Duchenne Muscular Dystrophy

Phase III trial finds that repurposed tamoxifen was safe but ineffective

Related Keywords

Switzerland ,Dirk Fischer ,Laurent Servais ,University Children Hospital Basel ,University Of Oxford ,Motor Function Measure ,University Children ,Hospital Basel ,North Star Ambulatory Assessment ,Upper Limb ,Personal Adjustment ,Role Skills Scale ,